Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Helix Biopharma Corp
(TSX:
HBP
)
0.7700
CAD
-0.0100 (-1.28%)
Streaming Delayed Price
Updated: 1:29 PM EST, Feb 26, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Helix Biopharma Corp
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Helix BioPharma Corp. Closes Private Placement
December 04, 2020
From
ACCESSWIRE
Helix Biopharma Corp. Provides Polish Subsidiary Divestiture Update
September 30, 2020
From
ACCESSWIRE
Helix BioPharma Corp. Provides Polish Subsidiary Divestiture Update
August 31, 2020
From
ACCESSWIRE
Helix BioPharma Corp. to Present at the SNN Network Virtual Conference
July 31, 2020
From
ACCESSWIRE
Helix Biopharma Corp. Announces Fiscal Third Quarter 2020 Results
July 30, 2020
From
GlobeNewswire News Releases
Helix BioPharma Corp. to Present at Alpha Bronze Virtual Town Hall
July 27, 2020
From
ACCESSWIRE
Helix BioPharma Corp. Provides Update On The Timing Of Filing Of Third Quarter Results
July 13, 2020
From
GlobeNewswire News Releases
Helix BioPharma Corp. to divest remaining ownership of Polish subsidiary
June 26, 2020
From
GlobeNewswire News Releases
Proactive Virtual Event Showcases Four Rising Stars of the Life Sciences Industry
June 22, 2020
From
GlobeNewswire News Releases
Helix BioPharma Corp. to Present at Proactive One2One Virtual Investor Forum
June 22, 2020
From
GlobeNewswire News Releases
Helix BioPharma Corp. Provides Update On The Timing Of Filing Of Third Quarter Results
June 11, 2020
From
GlobeNewswire News Releases
Helix BioPharma Corp. L-DOS47 Phase I Lung Cancer Trial Data to be released at ASCO 2020
May 14, 2020
From
GlobeNewswire News Releases
Helix BioPharma Corp. Provides Corporate Update
April 02, 2020
From
GlobeNewswire News Releases
HELIX BIOPHARMA CORP. ANNOUNCES FISCAL SECOND QUARTER 2020 RESULTS
March 16, 2020
From
GlobeNewswire News Releases
Helix BioPharma Corp. Closes $6.0 Million Private Placement
March 12, 2020
From
GlobeNewswire News Releases
Helix BioPharma Corp. to Present at the Noble Capital Markets’ Sixteenth Annual Investor Conference
February 14, 2020
From
GlobeNewswire News Releases
Helix BioPharma Corp. Closes $3.0 Million Private Placement
January 13, 2020
From
GlobeNewswire News Releases
Helix BioPharma Corp. to Present at the Biotech Showcase Conference in San Francisco
January 08, 2020
From
GlobeNewswire News Releases
Helix BioPharma Corp. Announces Fiscal First Quarter 2020 Results
December 13, 2019
From
GlobeNewswire News Releases
Helix BioPharma Corp. Commences L-DOS47 Phase lb/ll Pancreatic Cancer Clinical Study
December 11, 2019
From
GlobeNewswire News Releases
Helix BioPharma Corp. Reports Voting Results
December 06, 2019
From
GlobeNewswire News Releases
Helix BioPharma Corp. Announces Fiscal 2019 Year-End Results
October 25, 2019
From
GlobeNewswire News Releases
Helix BioPharma Corp. Board Changes
October 10, 2019
From
GlobeNewswire News Releases
Helix BioPharma Corp. and Moffit Cancer Centre to Present at World Molecular Imaging Congress
September 03, 2019
Pharmacodynamics of targeted urease and checkpoint blockade using Chemical Exchange Saturation Transfer and 31P-magnetic Resonance Spectroscopy
From
GlobeNewswire News Releases
Helix BioPharma Corp. Closes $7.0 Million Private Placement
August 21, 2019
From
GlobeNewswire News Releases
Helix Biopharma Corp. Receives U.S. FDA Approval for Phase Ib/II Pancreatic Trial
August 07, 2019
From
GlobeNewswire News Releases
Helix Biopharma Corp. to Present at RHK Capital Conference in New York
July 24, 2019
Helix BioPharma Corp. (TSX: HBP), (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, announces that it will be...
From
GlobeNewswire News Releases
Helix BioPharma Corp. Submits L-DOS47 IND Application With U.S. FDA for Pancreatic Cancer
July 09, 2019
Helix BioPharma Corp. (TSX: HBP), (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced the submission...
From
GlobeNewswire News Releases
Helix BioPharma Corp. Announces Fiscal Third Quarter 2019 Results
June 11, 2019
Helix BioPharma Corp. (TSX: HBP) (“Helix” or the “Company”), a clinical stage immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, announces its...
From
GlobeNewswire News Releases
Helix BioPharma Corp. Initiates OTCQB Application and Hires U.S. Investor Relations Firm
May 30, 2019
Helix BioPharma Corp. (TSX: HBP), (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, announced that it has...
From
GlobeNewswire News Releases
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.